2012-05-10T15:50:50Z Copyright (c) 2012, The RAND Corporation RAND Corporation http://www.rand.org/about/people/j/joyce_geoffrey_f.html http://www.rand.org/commentary/2006/01/13/UPI.html 2006-01-13T12:00:01Z 2006-01-13T12:00:01Z

The federal government's new Medicare prescription-drug benefit program for the elderly and disabled, which went into effect Jan. 1, has gotten off to a slow start, writes Geoffrey Joyce.

http://www.rand.org/commentary/2002/12/11/LAT.html 2002-12-11T21:51:00Z 2002-12-11T21:51:00Z

Adding a flexible drug benefit to Medicare would bring costs down, say Dana Goldman and Geoffrey Joyce in an LA Times commentary.

http://www.rand.org/commentary/2000/11/05/LAT2.html 2000-11-05T16:46:00Z 2000-11-05T16:46:00Z

Published commentary by RAND staff.

http://www.rand.org/pubs/monographs/MG237.html 2005-02-11T07:40:00Z 2005-02-11T07:40:00Z

Provides information about where TRICARE Senior Pharmacy beneficiaries receive their medications and what factors influence where they choose to obtain their medications.

http://www.rand.org/pubs/monographs/MG154.html 2005-02-08T07:18:00Z 2005-02-08T07:18:00Z

Assesses how changing to a three-tiered co-payment system would affect drug costs and pharmacy utilization, in particular for specific high-cost classes of medications.

http://www.rand.org/pubs/research_briefs/RB9169.html 2006-01-12T11:30:00Z 2006-01-12T11:30:00Z

This Research Brief summarizes the relationship between (1) co-payments and compliance for patients whose doctors prescribed cholesterol-lowering drugs, and (2) compliance and subsequent use of expensive health care services.

http://www.rand.org/pubs/research_briefs/RB9084.html 2005-11-25T04:58:00Z 2005-11-25T04:58:00Z

This research brief describes work documented in Pharmacy Use and Costs in Employer-Provided Health Plans: Insights for TRICARE Benefit Design from the Private Sector(MG-154-OSD) and Determinants of Dispensing Location in the TRICARE Senior Pharmacy Program (MG-237-OSD).

http://www.rand.org/pubs/research_briefs/RB4548.html 2002-01-01T00:00:00Z 2002-01-01T00:00:00Z

http://www.rand.org/pubs/research_briefs/RB9043.html 2004-01-01T00:00:00Z 2004-01-01T00:00:00Z

Researchers in RAND Health have conducted a series of studies analyzing obesity trends and estimating their effects on future health care costs.

http://www.rand.org/pubs/working_papers/WR269.html 2005-06-03T09:48:00Z 2005-06-03T09:48:00Z

Costs and Effects of Participation in Collaboratives to Improve Chronic Illness Care: Technical Appendix

http://www.rand.org/pubs/reprints/RP1224.html 2003-01-01T00:00:00Z 2003-01-01T00:00:00Z

Reviews the effectiveness of interventions used to promote smoking cessation among persons age 65 or older.

http://www.rand.org/pubs/external_publications/EP20070633.html 2007-01-01T00:00:00Z 2007-01-01T00:00:00Z

Increasing trends in the incidence of and costs associated with kidney cancer have been apparent for more than 10 years.

http://www.rand.org/pubs/external_publications/EP20100153.html 2010-01-01T00:00:00Z 2010-01-01T00:00:00Z

First dollar coverage for preventive services increases utilization modestly among healthy individuals, particularly those in lower deductible plans, but patients' predisposing characteristics merit attention.

http://www.rand.org/pubs/external_publications/EP20030504.html 2003-01-01T00:00:00Z 2003-01-01T00:00:00Z

ART appears to be responsible for both a treatment-specific and global improvement in the mental health of HIV+ patients.

http://www.rand.org/pubs/monograph_reports/MR1529z0.html 2002-01-01T12:01:41Z 2002-01-01T12:01:41Z

http://www.rand.org/pubs/monograph_reports/MR1790z0.html 2003-01-01T12:01:41Z 2003-01-01T12:01:41Z

Pharmacy Use and Costs in the TRICARE Senior Pharmacy Program: Insights for Benefit Design from the Private Sector

http://www.rand.org/pubs/external_publications/EP20070014.html 2007-01-01T00:00:00Z 2007-01-01T00:00:00Z

The overall objective of the project, Urologic Diseases in America, is to quantify the burden of urologic diseases on the American public. Until this project, no authoritative omnibus had compiled a comprehensive set of data analyses that synthesized information available from myriad national and regional sources across the public and private sectors in the United States.

http://www.rand.org/pubs/research_briefs/RB9285.html 2007-09-11T02:39:00Z 2007-09-11T02:39:00Z

This research brief examines the likely effects of the gap in the Medicare Part D standard drug benefit after $2,400 in pharmaceutical spending, using data from a private employer.

http://www.rand.org/pubs/external_publications/EP20070704.html 2007-01-01T00:00:00Z 2007-01-01T00:00:00Z

Prescription drugs are instrumental to managing and preventing chronic disease.

http://www.rand.org/pubs/external_publications/EP20070908.html 2007-01-01T00:00:00Z 2007-01-01T00:00:00Z

In this paper the authors examine medication use among retirees with employer-sponsored drug coverage both with and without annual benefit limits.